Clinical trial · Observational
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
NCT06610045CI-TRIAL-00087165completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this observational study is to estimate the burden of multiple myeloma on patients and caregivers in terms of QoL. Additionally, this study will assess the correlation between QoL, obtained from commonly used and validated questionnaires, and the perceptions of both patients and caregivers respectively., obtain from a 10-point scale and a comment box.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Caregiver Subjective Burden | — | UNRESOLVED | — |
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
| Quality of Life (QOL) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with multiple myeloma
- description
- Patients with multiple myeloma member of Myeloma Canada database
- interventionNames
- Other: No intervention
- label
- Caregivers of patients with myeloma
- description
- Caregiver of a multiple myeloma patient member of Myeloma Canada database
- interventionNames
- Other: No intervention
Primary outcomes (1)
- measure
- To estimate quality of life of patients with myeloma and caregivers of patients with myeloma
- timeFrame
- From enrollment until sample size is reached
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. 18 years of age or older; 2. Part of the Myeloma Canada database; 1. Identified as a patient with MM or 2. Identified as a current caregiver of a patient with MM at the time of participation. 3. Ability to read and understand English or French; 4. Signature of informed consent form (ICF). Exclusion Criteria: No exclusion criteria
References
Publications (0)
Data not yet available
No reference posted for this study.